We are live on ! Find out more
BIOC

Biocept, Inc.
BIOC

Delisted

BIOC was delisted on the 24th of October, 2023.

Back to rankings

11 hedge funds and large institutions have $803K invested in Biocept, Inc. in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

10% more funds holding

Funds holding: 10 → 11 (+1)

31% less capital invested

Capital invested by funds: $1.16M → $803K (-$356K)

Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
+$96.8K
2
Creative Planning
Creative Planning
Kansas
+$96.8K
3
Goldman Sachs
Goldman Sachs
New York
+$24.2K
4
MWM
Merriman Wealth Management
Washington
+$24.2K
5
UBS Group
UBS Group
Switzerland
+$24.2K

Top Sellers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
-$48.4K
2
VKH
Virtu KCG Holdings
New York
-$34K
3
HighTower Advisors
HighTower Advisors
Illinois
-$21K
4
William Blair & Company
William Blair & Company
Illinois
-$13K
5
BIM
BlackRock Investment Management
Delaware
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$273K +$24.2K +1 +7%
Creative Planning
2
Creative Planning
Kansas
$115K +$96.8K +4 +200%
BIT
3
BlackRock Institutional Trust
California
$113K – – –
GBA
4
Garrison Bradford & Associates
New York
$75K – – –
AFM
5
Anson Funds Management
Texas
$74K +$96.8K +4 New
Geode Capital Management
6
Geode Capital Management
Massachusetts
$54K – – –
CC
7
Callan Capital
California
$25K – – –
UBS Group
8
UBS Group
Switzerland
$15K +$24.2K +1 New
Northern Trust
9
Northern Trust
Illinois
$14K – – –
MWM
10
Merriman Wealth Management
Washington
$12K +$24.2K +1 New
Goldman Sachs
11
Goldman Sachs
New York
$11K +$24.2K +1 New
SCM
12
Sterneck Capital Management
Missouri
$7K – – –
TSS
13
Two Sigma Securities
New York
$7K – – –
BFA
14
BlackRock Fund Advisors
California
$3K -$48.4K -2 Closed
Morgan Stanley
15
Morgan Stanley
New York
$3K – – –
LTFS
16
Ladenburg Thalmann Financial Services
Florida
$2K – – –
HighTower Advisors
17
HighTower Advisors
Illinois
– -$21K -1 Closed
VKH
18
Virtu KCG Holdings
New York
– -$34K -1 Closed
BIM
19
BlackRock Investment Management
Delaware
– -$3K – –
William Blair & Company
20
William Blair & Company
Illinois
– -$13K – –

BIOC Hedge Fund Activity: Q2 2016 in Review

11 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q2 2016, worth a combined $803K — down 31% from $1.16M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new BIOC positions and 3 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $96.8K. The largest seller was BlackRock Fund Advisors, exiting entirely with an estimated $48.4K sold.

  • 11 institutional investors held Biocept, Inc. (BIOC) as of Q2 2016, up from 10 in Q1 2016.
  • Funds reported $803K of Biocept, Inc. stock for Q2 2016, down 31% quarter-over-quarter.
  • 4 funds opened new Biocept, Inc. positions in Q2 2016 and 3 closed out, a net change of +1 holder.
  • The largest Biocept, Inc. buyer in Q2 2016 was Anson Funds Management, an estimated $96.8K added.
  • The largest Biocept, Inc. seller in Q2 2016 was BlackRock Fund Advisors, an estimated $48.4K sold.

Based on aggregated 13F filings for Q2 2016.